Fingerprint
Dive into the research topics of 'The Cost-Effectiveness of Axicabtagene Ciloleucel as Second-Line Therapy in Patients with Large B-Cell Lymphoma in the United States: An Economic Evaluation of the ZUMA-7 Trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically